Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2) von Swisher, EM, Kwan, TT, Oza, AM, Tinnker, AV, Ray-Coquard, I, Oaknin, A, Coleman, RL, Aghajanian, C, Konecny, GE, O'Malley, DM, Leary, A, Provencher, D, Welch, S, Chen, L-M, Wahner Hendrickson, AE, Ma, L, Ghatage, P, Kristeleit, RS, Dorigo, O, Musafer, A, Kaufmann, SH, Elvin, JA, Lin, DI, Chambers, SK, Dominy, E, Vo, L-T, Goble, S, Maloney, L, Giordano, H, Harding, T, Dobrovic, A, Scott, CL, Lin, KK, McNeish, I

Volltext